NM_017780.4:c.8639C>T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2
The NM_017780.4(CHD7):c.8639C>T(p.Pro2880Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000471 in 1,613,934 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_017780.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152232Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000802 AC: 2AN: 249252Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135224
GnomAD4 exome AF: 0.0000486 AC: 71AN: 1461702Hom.: 0 Cov.: 31 AF XY: 0.0000399 AC XY: 29AN XY: 727132
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152232Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74380
ClinVar
Submissions by phenotype
not provided Uncertain:4
CHD7: PM2, BP4 -
- -
- -
Reported in a patient with idiopathic hypogonadotropic hypogonadism (IHH) and cryptorchidism; however, information about parental testing was not provided (Kim et al., 2008); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 21856375, 22035731, 22539353, 18834967, 31501239) -
not specified Uncertain:2
The p.Pro2880Leu variant in CHD7 has been reported in at least 1 individual with hypogonadotropic hypogonadism (Kim 2008, Quaynor 2011), but has not been report ed in individuals with hearing loss. It has also been identified in 2/111680 of European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.b roadinstitute.org/; dbSNP rs113938624). Computational prediction tools and conse rvation analysis suggest that the p.Pro2880Leu variant may not impact the protei n, though this information is not predictive enough to rule out pathogenicity. I n summary, the clinical significance of the p.Pro2880Leu variant is uncertain. A CMG/AMP Criteria applied: PM2, BP4. -
Variant summary: CHD7 c.8639C>T (p.Pro2880Leu) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 249252 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.8639C>T has been reported in the literature in individuals affected with Hypogonadotropic Hypogonadism. These reports do not provide unequivocal conclusions about association of the variant with Hypogonadotropic Hypogonadism 5 With Or Without Anosmia. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -
CHARGE syndrome;C3552553:Hypogonadotropic hypogonadism 5 with or without anosmia Uncertain:1
- -
CHARGE syndrome Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at